Simplify Asset Management Partners with Premialab
Innovative Institutional-Grade Provider Chooses Premialab Technology for QIS Research, Performance, and Risk Management LONDON and NEW YORK, Feb. 13, 2024 /PRNewswire/ — Premialab, a leading provider of data, analytics, and risk solutions, today announced that Simplify Asset Management had
Unicorn Underwriting announces trading at Lloyd’s
LONDON, Feb. 13, 2024 /PRNewswire/ — Unicorn Underwriting announces it has secured a box at Lloyd’s. From Monday 12th February, you’ll be able to find Unicorn’s property underwriters at box 369 on gallery 3. The move demonstrates Unicorn’s commitment to maintaining exce
Oracle Helps Customers Drive Efficiency in Global Supply Chains
New logistics capabilities in Oracle Cloud SCM help customers increase visibility, reduce costs, automate compliance, and improve decision-making MUMBAI, India, Feb. 13, 2024 /PRNewswire/ — Oracle CloudWorld — To help organizations increase the efficiency of global supply chains, Oracle
Food Safety Monitoring System Market to Reach $63.5 Million by 2032 at 6.1% CAGR: Allied Market Research
The growing concerns about food safety, the ease of access to different food safety testing techniques, and the increasing healthcare costs are expected to drive the global food safety monitoring system market’s growth during the forecast period. The North America region is projected to witnes
HANZA Year-end report 2023
KISTA, Sweden, Feb. 13, 2024 /PRNewswire/ — HANZA AB reports that a successful quarter closed the year 2023. Sales exceeded SEK 1 billion with an operating margin of 8.4% (6.3), excluding acquisition costs. For the full year 2023, the group thus reaches an operating margin of 8.4 % (6.0). Duri
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights
HERZLIYA, Israel and CALGARY, AB, Feb. 13, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”), is pleased to provide the following corporate update: Innocan is uniquely positioned within the pharmaceutical tec
Synechron Affirms Productivity Benefits of GitHub Copilot
PUNE, India, Feb. 13, 2024 /PRNewswire/ — Synechron, Inc., a leading global digital transformation consulting firm focused on financial services and technology organizations, has deployed GitHub Copilot, a premier and widely adopted AI developer tool, for broad use by its developers in India.
Repurchases of shares by Concentric AB during week 6, 2024
REDDITCH, England, Feb. 13, 2024 /PRNewswire/ — Between 5 February 2024 and 9 February 2024 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 19,025 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The rep
Navamedic ASA: Invitation to 2023 4th quarter presentation
OSLO, Norway, Feb. 13, 2024 /PRNewswire/ — Navamedic ASA (OSE: Nava) will be presenting its fourth quarter 2023 results on Thursday, February 15, 2024. The presentation will be held at Dronning Eufemias gate 16 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presen
Implantica announces first RefluxStop™ public tender win, paving the way for permanent reimbursement in Italy
VADUZ, Liechtenstein, Feb. 13, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Hospital Santa Croce of Moncalieri, Turin, Regione Piemonte, Italy, has won the first-ever public tender for RefluxStop™.
